Summary
This laboratory study elucidates a mechanistic role for tumour cell-derived angiopoietin-like protein 2 (ANGPTL2) in promoting glycolytic metabolism—a hallmark of aggressive cancer phenotypes—in lung cancer cells. The authors demonstrate that ANGPTL2 activates the glucose transporter GLUT3 via integrin α5β1-mediated TGF-β signalling and downstream ZEB1 expression, and validate this signalling axis in primary patient tumour samples. The work suggests ANGPTL2 coordinates metabolic reprogramming with enhanced tumour cell invasiveness and metastatic potential.
UK applicability
This mechanistic laboratory study does not directly address UK farming systems, soil health, or food-based nutrition. Its findings are relevant to cancer biology research and may inform therapeutic development but have limited applicability to agricultural or public health policy in the UK context.
Key measures
GLUT3 expression levels, glycolytic metabolism rates, TGF-β signalling activity, ZEB1 transcription factor expression, integrin α5β1 signalling, cell metastatic capacity
Outcomes reported
The study demonstrated that tumour cell-derived ANGPTL2 upregulates GLUT3 glucose transporter expression and enhances glycolytic metabolism in lung cancer cells through a TGF-β–ZEB1 signalling pathway. ANGPTL2 expression levels correlated with GLUT3 expression in primary lung cancer patient samples.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.